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Abstract Toll-like receptors are pattern recognition recep-
tors with which hosts recognize pathogen-associated
molecular patterns (PAMP). This recognition process is
translated rapidly into a meaningful defense reaction. This
form of innate host defense is preserved in the animal
kingdom: invertebrates heavily depend on it; higher
vertebrates also have an adaptive immune system. Both
adaptive and innate immune systems are intertwined in that
the former also depends on an intact innate recognition and
response system. Members of the TLR system cover
recognition of parasitic, bacterial or viral germs. Due to
the constraints imposed by the necessity to recognize
PAMP and to interact with downstream signaling mole-
cules, the TLR system is relatively conserved in evolution.
Nevertheless, subtle species differences have been reported
for several mammalian TLR members. Examples of this
will be given. In all mammalian species investigated, part
of the coding sequence is available for the most important
TLR members, thus allowing study of expression of these
TLR members in various tissues by reverse-transcription
polymerase chain reaction in its classical (RT-PCR) and
quantitative real time RT-PCR (qRT-PCR) form. In some
species, the whole coding sequences of the most important
or even all TLR members are known. This allows
construction of cDNA and transfection of common host
cells, thus permitting functional studies. Extensive inves-
tigations were devoted to the study of non-synonymous
single nucleotide polymorphisms. In a few cases, expres-
sion of a given amino acid in the extracellular (ligand-
binding) portion of TLR members could be associated with
infectious diseases. This will be discussed below.
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Introduction
Toll-like receptors (TLR) are a family of germ-line-encoded
receptors of the innate immune system. Collectively, they
cover the recognition of a wide variety of pathogens
(viruses, bacteria, blood-borne parasites), thereby inducing
a fast and appropriate host defense reaction against these.
Being conserved in evolution, they represent the prime host
defense mechanism of invertebrates and lower vertebrates.
In higher vertebrates (from gnathostomes up), they are not
only essential for sensing microbes by the innate immune
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system but also for inducing a clonally restricted, antigen-
specific response in the adaptive immune system, mediated
by B and T cells (Medzhitov et al. 1997). This chapter
briefly reviews how interest arose in TLR members, then
lists some burning questions in different species, summa-
rizes the approaches that have to be taken when studying
the TLR system in domestic animals, and finally goes more
specifically into what is known in species of domestic
animals.
Early investigations in invertebrates
The term “toll-like receptors” suggests that there is also a
“toll”. Indeed, when a doctoral student in the laboratory of
Nuesslein-Volhard found that, in a Drosophila mutant in
which a gene was lacking, the dorsoventral orientation of
larvae was ablated, she expressed, in her German, “toll”
(great), and thus a gene important for the larval develop-
ment of Drosophila melanogaster was named (Anderson
et al. 1985). The ligand of that receptor was not a pathogen,
but a cleaved fly glycoprotein with the name of “spaetzle”
(Morisato and Anderson 1994). Later on, it was realized
that the cell-membrane-expressed receptor “Toll” also has
an important function in adult flies by mediating the
recognition of fungi and inducing a meaningful host
response against these (Lemaitre et al. 1996). This
fundamental observation was the reason for also looking
for “Toll” in higher vertebrates (see below).
Early investigations in vertebrates
There are two early traces of linking mammals to TLR: (1)
the seminal discovery that TLR4 is the signaling part of the
lipopolysaccharide (LPS) receptor (Poltorak et al. 1998)
alluded to in more detail by Van der Pool (2010, this issue),
and (2) the observation that innate immune recognition by
the TLR is essential for the mounting of an adaptive
immune response (Medzhitov and Janeway 1997). After
these pivotal observations, the area virtually exploded, and
rapid progress was made particularly with regard to innate
recognition of pathogens and their products. Fascinatingly,
Toll homologues or TLR are highly conserved between
invertebrates and vertebrates. A great number of different
TLR have been identified, and the number of expressed
receptors varies between species from 1 in the nematode
Caenorabditis elegans (Kanzok et al. 2004) to 222 in the
sea urchin Strongylocentrotus purpuratus (Roach et al.
2005). In higher vertebrate species, 13 TLR members have
been identified, subsumed in the following as the TLR
system. For 10 of them, natural ligands of pathogens are
known. Subsequently, discoveries were made rapidly in
mice and humans, particularly with regard to the binding
specificity of members of the TLR family, and to the
signaling chains involved. To knockout genes involved
either in the sensing of pathogens or in signaling and
mediating a defense reaction was central. There are a
number of excellent reviews of these findings (Akira et al.
2001; Kaisho and Akira 2006; Beutler et al. 2006; Werling
and Coffey 2007); one might also study this special issue.
However, the expression and function of TLR by domestic
animals lagged behind. This area has been comprehensively
reviewed by Turin and Riva (2008). While there are a total
of 13 TLR members described in mammals, there are 10
genes in most mammals, 10 genes in the chicken, 3 of
which are unique to birds (Temperley et al. 2008), and
approximately 17 genes in all bony fishes investigated so
far (Rebl et al. 2010).
Receptors for pathogen- or microbe-associated
molecular patterns?
Those who coined the expression “pathogen-associated
molecular patterns (PAMP)” meant that protection against
certain pathogenic microbes is achieved by innate recogni-
tion and an appropriate defensive response against these
microbes. Put another way, their wording suggests that it is
the immune system that discriminates between benign
microbes and harmful pathogens compromising the health
of the host. That this concept cannot be maintained, in the
case of the TLR system, was realized soon thereafter, and
the term “microbe-associated molecular pattern (MAMP)”
was coined (Mackey and McFall 2006). In the case of a
viral infection, one could argue that any intrusion of a virus
into host cells in vivo is inappropriate regardless of the
pathogenicity of the virus, and therefore any virus has to be
regarded as pathogenic. Thus, in the case of a viral
infection, the terms PAMP and MAMP have the same
meaning. But what discriminates a harmless bacterial
intruder from a truly pathogenic bacterium? Both are
recognized by the TLR system. That there is a difference
between PAMP and MAMP becomes immediately obvious
in the case of the gastrointestinal tract harboring myriads of
benign bacteria but depending—so it is believed—on the
TLR system to cope with a potentially harmful pathogen.
Rakoff-Nahoum et al. (2004) even reported that stimulation
of the TLR system is absolutely required for a normal
development of the gastrointestinal tract. There is no doubt
that non-pathogenic bacteria also trigger the TLR system,
which consequently fails to discriminate between benign
and pathogenic bacteria. What exactly characterizes patho-
genic bacteria or blood parasites and distinguishes them
from harmless counterparts is unknown. It has been
suggested that it is the strategic positioning that allows
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discrimination (Gewirtz et al. 2001). Accordingly, benign
bacteria are localized only in the colon lumen, where they
are disregarded by the TLR system. In contrast, the flagellin
of pathogenic Salmonellae gets access to the basolateral
side of the epithelium where it is sensed by basolaterally
expressed TLR5. (This, however, does not explain why in
fishes there is a soluble variant of TLR5, TLR5S; see
below.) The finding of Burgener et al. (2008), that
dysregulated TLR expression of dogs with inflammatory
bowel disease is not normalized after these dogs are treated
and get clinically better, is illustrative in this context. It
suggests that a healthy, not dysregulated, TLR system in the
gastrointestinal tract is finely balanced in order to protect a
host from infection on one hand and to avoid inflammatory
sequelae triggered by the immune system in its fight against
the intruder on the other hand. Be this as it may, the very
properties of PAMP sensed by pattern recognition receptors
(PRR) are incompatible with a discrimination between
benign and pathogenic bacteria. For investigators of the
gastrointestinal tract and its immunology, it is advised to
give priority to the term MAMP over PAMP.
Binding specificity of mammalian TLR members
It is agreed that three preconditions are required for a
PAMP to qualify as such and to be recognized by PRR such
as TLR: (1) its broad expression by large groups of
potential pathogens; (2) its essentiality for survival and
successful propagation of the pathogen in question; and (3)
its absence from tissues of the host species. The TLR
system of higher vertebrates, which is discussed here,
perfectly qualifies as a pattern recognition system that
covers sensing of the full spectrum of microbes. (Although
more PAMP were reported to be recognized by the TLR
system, some of which are probably endogenous, and only
the most important ones are summarized here, and a
discussion as to whether other potential TLR agonists exist
is avoided.) TLR4 is the first identified and probably best-
studied TLR. In cooperation with three other proteins, the
lipopolysaccharide binding protein (LBP), CD14 and MD-
2, it is responsible for the sensing of lipopolysaccharide
(LPS), the so-called endotoxin of gram-negative bacteria
(Poltorak et al. 1998; Medzhitov et al. 1998; Sauter et al.
2007). The heterodimer formed between TLR2 and TLR6
or TLR1 is able to recognise diacylated or triacylated
lipopeptides (LP) found on the surface of all bacteria,
respectively (Takeda et al. 2003; Kawai and Akira 2006).
TLR5 recognizes flagellin of bacteria (Hayashi et al. 2001).
TLR9 binds motifs of CpG DNA, i.e. stretches that are
frequently found in microbial DNAwhereas they are rare in
higher vertebrates, and if expressed, they are methylated
and are therefore inaccessible for TLR9 recognition
(Hemmi et al. 2000). TLR3 recognizes double-stranded
RNA (Alexopoulou et al. 2001). TLR7 and 8 recognize
imidazoquinolines used as antiviral compounds (e.g.,
imiquimod and resiquimod). Later, it was first realized by
Heil et al. (2004) that TLR7 and 8 recognize single-
stranded RNA, as often occurring in viruses. TLR3, 7,
8 and 9 are expressed in endosomal vesicles (Fig. 1),
thereby being separated from host nucleic acids. TLR11,
present only in the murine system, senses uropathogenic
bacteria, although the exact PAMP, at the molecular level,
is unknown. Ligands for TLR10 and members with
numbers >11 are not yet known in mammals, but have
been identified in chicken and fish, potentially representing
the homologues of mammalian TLR.
In the literature, one finds the statement that TLR2
heterodimers recognize lipoteichoic acid (LTA) and pepti-
doglycan (PG) (Schwandner et al. 1999). The TLR
Cytoplasmatic portion of
TLR1,2,4,5,6: TIR domain
Cytoplasmatic portion of
TLR3,5,8,9: TIR domain
Cytoplasma
Extracellular, leucine-rich repeats
of TLR1,2,4,5,6
Lumen of granules
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Fig. 1 Illustration of localiza-
tion of various mammalian TLR
in cells. TLR consist either of
extracellular or intraluminal
LRR recognizing the PAMP
(upright green ellipses), of a
short transmembrane region (not
shown) and of cytoplasmatic
TIR domains (green circles).
Endosomal vesicles: white
circles. Cell nucleus: dark gray
circle
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requirement for LTA recognition is controversial (Schwandner
et al. 1999; Takeuchi et al. 1999). LTA preparations are
notoriously contaminated by lipopeptides (LP); and there is
evidence that the active components of LTA are contaminat-
ing LP (Hashimoto et al. 2006). Likewise, there is published
evidence that PG are recognized by NOD1/NOD2, but not
by TLR2. Instead, an LP contamination of PG and present in
most PG preparations appears to be recognised by TLR2
(Travassos et al. 2004). Thus, a contamination by LP is
underestimated by most studies. Farhat et al. showed that
commercial LPS preparations but not ultra-pure LPS
preparations from E. coli are recognised by boTLR2- and
boTLR1-transfected cells (in preparation; Fig. 2), although
all LPS preparations tested, including the ultra-pure LPS,
proved to be agonists of TLR4. These authors concluded that
LP contaminations are widespread and may confuse inter-
pretation of the results. It has been suggested that TLR2 is
not a promiscuous receptor for gram-positive bacteria and
many blood-borne parasites; instead, its heterodimers are
receptors for the recognition of di- or triacylated LP and LP-
contaminated preparations (Zähringer et al. 2008). TLR10,
which is expressed in humans, is closely related to TLR-1
and 6, and appears to also recognize triacylated LP, but the
signaling mechanisms are apparently different for the TLR1/
2 and TLR-2/10 heterocomplexes (Guan et al. 2010).
Signaling through TLR (see Pierce (2010) in this special
issue for details)
After discovery of the TLR system, a lot of effort went into
characterizing its signaling pathways (Kaisho and Akira
2006). It is amazing how conserved these are, as the one for
Toll in Drosophila and the most widespread signaling
pathway in mammals are homologous to each other.
Whereas TLR2 forms heterodimers with TLR1 or TLR6,
and TLR4 probably forms multimeric complexes, upon
engagement, it is not clear whether TLR3, TLR5, and TLR
7–9 also require multimerization for activating a signal
transduction chain, At least in the case of TLR9, evidence
for an allosteric effect has been provided (Latz et al. 2007).
What is, however, clear is that all TLR contain a Toll-
interleukin-1-receptor (TIR) domain that binds another
intracellular adapter protein, called MyD88, with the
exception of TLR3. In the case of all known TLR members
except TLR3, the engagement/activation of MyD88 results
in activation of the kinase IRAK-4 (interleukin-1-receptor
associated kinase number 4) which phosphorylates/activates
IRAK-1, leading to Traf6 (TNF receptor-associated factor
number 6) activation. This ultimately results in the cleaving
of the NF-κB-IκB complex. Whereas IκB is phosphorylated
and degraded, the liberated NF-κB has access to the nucleus
where it acts as a transcription factor, resulting in the up-
regulation and/or induction of many host defense-related
genes. TLR2 and TLR4 engagement preferentially use a TIR
adapter molecule other than MyD88, namely Mal, in order to
activate NFκB. In the case of TLR3, the activated TIR
domain interacts with still another intracellular adapter
molecule called TRIF, resulting in the induction of type-1
interferon (IFN). In the case of TLR4, one of five TIR
adaptors (MyD88, Mal, TRIF, TRAM, SARM; see review of
Kenny and O’Neill 2008) can be activated which culminates
in both nuclear translocation of NF-κb and induction of IFN.
IFN is exported and binds to its receptor (IFNAR) of
producing and/or neighboring cells, which induces the
production of more type-1 IFN. Thus, both signaling
cascades lead either to activation of NFκB (all mammalian
TLR members except TLR3) or to type-I-IFN induction
(mammalian TLR3 and 4). NF-κB is associated with the
induction of many genes having a role in immunity, and in
the activation of prominent cytoplasmatic enzymes (Remer
et al. 2003), up-regulation of surface-expressed molecules
and induction of dendritic cell maturation. The latter protects
neighboring target cells from viral infection. Type-1 IFN is
antiviral, but whether it also has a protective effect in
bacterial infections is controversial. The older literature also
ascribes to type 1 IFN a protective role in bacterial (e.g.,
listerial) infections. There are three more recent papers
suggesting that type-1 IFN has a harmful effect in listerial
infection (Auerbuch et al. 2004; Carrero et al. 2004;
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Fig. 2 The production of IL-8 by HEK293 cells stably transfected
with both boTLR1 and boTLR2 and stimulated with 100 nM of either
commercial or ultra-pure (u-p) LPS from E. coli. The numbers 1 and 2
refer to two lots of LPS kindly provided by Dr. H. Brade, Borstel
Research Center. Commercial LPS include LPS from E. coli and
purified by phenol extraction (phenol), precipitated by trichloroacetic
acid (TCA), purified by gel filtration (GF) or by isoelectric focussing
(IE). Controls were transfected cells stimulated by 10 mM TNF,
100 mM dipalmitoylated (Pam2) or 100 mM tripalmitoylated (Pam3)
cysteyl-seryl-lysyl-lysyl-lysyl-lysine (CSK4). IL-8 production was
measured 24 h after stimulation, and means ± 2SD were plotted.
The graph shows a representative experiment
110 Cell Tissue Res (2011) 343:107–120
O’Connell et al. 2004). Whether this can be generalized to
any bacterial infection is an open question.
Recently, it was found that certain factors limit a TLR2-
or TLR4-mediated NF-κB activation. The first molecule
identified in such an inhibitory loop was Tollip (Burns et al.
2000). The Tollip molecule phosphorylated by IRAK1
ubiquitinylates IRAK1, thereby marking it for degradation
by the proteosomal degradation pathway and producing less
free NF-κB.
Approaches to be taken to study the TLR
system in domestic animals
In the following, it will be summarized which methods are
generally used, and are most successful when studying
TLR members of domestic animals. These include reverse
transcription-polymerase-chain-reaction (RT-PCR) both in
its classical form and the more quantitative real time-RT-
PCR (qRT-PCR) form, transfection, flow cytometry,
immunohistochemistry (IHC), electron-microscopic im-
munocytochemistry (EMICC), and stimulation in vitro
by putative TLR agonists. The sequencing, which of
course is very important, is not especially mentioned.
RT-PCR and qRT-PCR
If part of the nucleotide sequence of the TLR member
concerned is available, one can use either RT-PCR or qRT-
PCR to look for expression of the TLR member concerned
at the mRNA level. This method is meaningful, particularly
for purified cells in solution (e.g., blood cells), or for tissues
available in highly purified form. It does not consider the
heterogeneity with regard to tissue and cell content of
organs. The expression of a given TLR member by
heterogenous tissue requires IHC or EM-ICC in order to
identify the tissue concerned, which means that antibodies
must be available (see below), or in situ hybridization,
which is not sensitive enough. The study of the expression
of the TLR system in various tissues is therefore in its
infancy.
Transfection
If the whole coding sequence of a given TLR member is
available, one can clone the TLR in question and make
DNA constructs to be used for transfection. Usually, in cells
not expressing a certain trait but acquiring it when the
cDNA is transfected, it can be measured whether TLR-
mediated activation of cells is co-transfected. Care has to be
taken in interpreting the data since the recipient cell may
express endogenous TLR members heterodimerizing with
the transfected TLR member, thereby activating the cell line
in the presence of an appropriate MAMP. For example,
bovine TLR2 transfected alone was active upon stimulation
of the cells with diacylated lipopeptides, but it was
suspected that transfected bovine TLR2 heterodimerized
with endogenous (human) TLR6 in the HEK293 cells
studied (Farhat et al. 2008, 2010). This promising approach
has been taken up by several groups (e.g., Schwarz et al.
2007; Yang et al. 2008; Farhat et al. 2008).
Anti-TLR antibodies
If TLR-specific antibodies are available, one can localize
expression of the TLR member concerned, for example
using flow cytometry, IHC or EMICC. Various TLR-
specific antibodies, including monoclonals, are sold
commercially, and they recognize specifically TLR mem-
bers. Sadly enough, not many of these are useful for
studying the TLR system of domestic animals. This could
have two reasons: (1) due to the large degree of
conservation, not enough antigenic differences between
the species of antibody induction and the antigen chosen
is observed; (2), and more likely, due to the focusing on
the study of the murine and the human TLR system,
domestic animal species have the role of a Cinderella and
are insufficiently investigated. A study of Burgener and
Jungi (2008) provided evidence that commercial anti-
bodies recognizing, with high affinity, human TLR and
useful in flow cytometry, also cross-react with canine
TLR. By immunizing rabbits with peptides derived from
canine TLR members, a specific staining of canine
mesenterial lymph node was obtained, and it is suggested
that these represent the canine variant of TLR members
(Fuog et al., submitted). Thus, polyclonal antibodies
against TLR members of domestic animals can be made.
The laboratory of Dominguez was successful in generating
monoclonals specific for porcine TLR2 (Alvarez et al.
2008). Unfortunately, this monoclonal failed to recognize
bovine cells (Jungi and Dominguez, unpublished). Others
were successful in generating polyclonal pig TLR2-
specific (Tohno et al. 2005a) and pig TLR9-specific
antibodies (Shimosato et al. 2005). Due to a lack of
antibodies specific for TLR members of domestic animals,
one often resorts to quantitative real-time RT-PCR to study
the expression of TLR members (see below). As outlined
below, for most species, complete or partial coding
sequences of the most important TLR members are
known.
Cultivation of cells in the presence of TLR agonists
Cells expressing TLR (either autochthonous or transfected)
are stimulated with highly purified agonists of TLR [LPS,
synthetic diacylated or triacylated LP, poly(I:C), single
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stranded or double-stranded RNA, CpG DNA] or growth-
arrested whole gram-positive or gram-negative bacteria
(Farhat et al. 2008), and induction of an appropriate
effector function is measured, depending on the cells
stimulated. This can range from measurement of a cytokine
by ELISA, up-regulation of transfected surface molecules
such as ELAM-1 by flow cytometry (Schwandner et al.
1999), to any other function whose expression in the cells
studied is TLR-dependent.
Analysis of TLR in domestic animals
Being a conserved system, it is clear that one cannot expect
dramatic inter-species changes for the TLR system, as most
domestic animal species are mammals. However, in
evolutionary terms, interesting observations were made in
birds, in teleostean fishes and in lamprey. The review of
Turin and Riva (2008) also alluded to some of these
species. To allow an estimation on evolutionary dynamics,
homologies of DNA of genes are indicated.
Guinea pig
In the guinea pig, TLR2, 3, 4, 7 and 8 have been worked on
(Kuno et al. 2009; Astakhova et al. 2009; Kawahara et al.
2001). This is a species of lesser importance in present-day
immunology. Nevertheless, one of the first studies using a
pharmacological TLR4 antagonist has been reported in this
species (Kuno et al. 2009).
Rabbit
Only TLR3, 4, and 7 have been addressed by researchers of
rabbits (Astakhova et al. 2009; Zhou et al. 2007), as this is
also a species of lesser interest in present-day immunology.
Cattle
This is one of the well-investigated species of domestic
animals. Thus, the complete coding sequence of TLR1–10
is known (Menzies and Ingham 2006; Seabury et al. 2007,
2010; Turin and Riva 2008), with genes mapped to
chromosomes (McGuire et al. 2006). Research has
addressed additional questions such as the degree of
polymorphism (see below). The nucleotide homology to
human TLR genes is, on average, 65–77%, and 98% to the
closely related nilgai or water buffalo genes in the same
subfamily (amino acid similarity is 97%; Turin and Riva
2008). This enabled Vaharan et al. (2008) to establish
primers for assessing nilgai TLR mRNA and to study
expression by RT-PCR of TLR genes in various nilgai
organs.
Small ruminants
The sheep genome was found to contain, as is typical for
mammals, TLR1–10 and partial coding sequences are
available for sheep (Menzies and Ingham 2006; Bhide
et al. 2009; Chang et al. 2009; Turin and Riva 2008). It was
reported to express the “human” rather than the “murine”
type of TLR members (Nalubamba et al. 2007). Primers of
ovine TLR to be used in qRT-PCR were published, based
on partial sequences (Menzies and Ingham 2006), and
expression in various tissues has been reported (Table 1).
For both ovine TLR7 and 8, two variant genotypes are
available. For all TLR genes in the ovine genome, the
homology to bovine orthologues is >95%.
Based on the high degree of relatedness between sheep
and goat, Tirumurugaan et al. (2010) succeeded in defining
primers available for RT-PCR of goat TLR1-10 and in
measuring the level of expression in various tissues
(Table 1). Sequencing the amplified products revealed, as
was expected, that there is a close match between ovine and
caprine TLR (Tirumurugaan et al. 2010).
Pig
Genes expressing all TLR members known in humans and
porcine MyD88 have been cloned (Bergman et al. 2010;
Astakhova et al. 2009; Shinkai et al. 2006a; Bailey 2009;
Tohno et al. 2007; Turin and Riva 2008) showing a
nucleotide homology of DNA of 65–77% with human
TLR orthologues. The gene coding for porcine MyD88 is
87% homologous to the human MyD88 gene.
Horse
Equine TLR2, 3, 4, 5, 7 and 8 have been fully sequenced
(Turin and Riva 2008; Astakhova et al. 2009). For TLR9,
part of the sequence is known, allowing qRT-PCR to be
performed (Schneberger et al. 2009; Sharma and Maheshwari
2009). Compared with human TLR genes, the equine
counterparts have a nucleotide homology of 65–77%.
Cat
In the cat, the first 9 TLR members have been partially
cloned and sequenced, and the genes have been analyzed
(Ignacio et al. 2005; Turin and Riva 2008). Again,
compared with human TLR genes, homology is somewhere
between 65 and 77% (TLR4) and 90% (TLR9).
Dog
Complete cDNA sequences are available only for TLR2,
4, and 9 (Asahina et al. 2003; Hashimoto et al. 2005; Ishii
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et al. 2006). Compared with human TLR genes, the
nucleotide homology is between 65 and 77% (TLR4) or
88% (TLR2, 9).
Birds
We are now coming to non-mammalian species. Due to the
larger distance to any given mammal, the phylogenetic
aspect of a system putatively being under evolutionary
pressure becomes more obvious (Temperley et al. 2008).
The new names, as suggested by Temperley et al. (2008),
are used. The chicken, i.e. the bird studied best, is used as
representative. Some of the genes have orthologues in
mammals (TLR3, 4, 5, 7), while TLR8 and TLR9 are
lacking, and the mammalian TLR1, 6 and 10 being in
mammals on the same chromosome are replaced by
Table 1 Expression of TLR members by various organs from mammalian domestic animal species
Species Organ Finding Method Reference
Cattle (Ruminantia) Skin TLR7,2>3,5,8>1>6,9,10; 4 low, 6 lacking qRT-PCR Menzies and Ingham (2006)
Lung TLR4 expressed; PIM have high LE IHC;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
9
>
>
=
>
>
;
Wassef et al. (2004)
Small intestine TLR4 expressed
Skeletal muscle Negative for TLR4
Liver TLR4 expressed
Spleen TLR4 expressed
Nilgai (Ruminantia) Mononuclear cells TLR2-10 expressed RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
9
>
>
>
>
>
>
=
>
>
>
>
>
>
;
Vaharan et al. (2008)
Neutrophils TLR1-10 expressed except TLR3
Spleen TLR1-10 expressed
Kidney TLR2,5,7,9 expressed
Lung TLR1-10 expressed
Liver TLR1-10 expressed
Heart All TLR expressed except TLR10
Uterus TLR2,5,7-10 expressed
Ovary TLR2-10 expressed
Sheep (Ruminantia) Jejunum TLR6>7,10>TLR2>TLR3-5,8,9>TLR1 qRT PCR
qRT PCR
qRT PCR
9
=
;
Menzies and Ingham (2006)Peyers patches Same as above, but weaker
Mesent. lymph node Same as above, but weaker, still
Goat (Ruminantia) Blood High LE of TLR1-9; TLR10 lacking RT PCR
RT PCR
RT PCR
RT PCR
RT PCR
9
>
>
=
>
>
;
Tirumurugaan et al. (2010)
Lung High LE of TLR1-9, TLR10 lacking RT-PCR
Lymph node High expression of TLR1-10
Jejunum High expression of TLR1,5,7-9>TLR6,10
Skin Low expression of TLR2,3,4,8,9,10
Pig (Perisso-dactyla) Intestinal M cells TLR2 LE high>TLR1,3-10 qRT-PCR, IHC (Tohno et al. 2005b)
Peyers patches TLR2 and TLR9 LE high qRT-PCR, IHC (Tohno et al. 2006)
Lung TLR4 expressed; PIM have high LE of TLR4 ICH;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
9
>
>
=
>
>
;
Wassef et al. (2004)
Small intestine TLR4 expressed
Skeletal muscle Negative for TLR4
Liver TLR4 expressed
Spleen TLR4 expressed
Mesent. lymph node TLR2 LE high
Horse (Perisso-dactyla) Lung TLR 9 expressed; LE high in PIM, subject to modulation qRT-PCR Schneberger et al. (2009)
Lung TLR4 in lungs; TLR2 only in PIM, subject to modululation qRT-PCR, IHC, EMICC Singh Suri et al. (2006)
Dog (Carnivora) Lung TLR4 expressed; PIM LE high IHC;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
IHC;EMICC
9
>
>
=
>
>
;
Wassef et al. (2004)
Small intestine TLR4 expressed
Skeletal muscle Negative for TLR4
Liver TLR4 expressed
Spleen TLR4 expressed
Synovial joint TLR2 and 4 expressed qRT-PCR; IHC (TLR4) Kuroki et al. (2010)
Only TLR4 subject to modulation by disease
Intestine TLR2,4,9 expressed, subject to modulation qRT-PCR Burgener et al. (2008)
1°CEC TLR2 and 4 expressed; subject to modulation RT-PCR Swerdlow et al. (2006)
Cat (Carnivora) Lymphocyte subsets TLR1-9 expressed, subsets variable qRT PCR
qRT PCR

Ignacio et al. (2005b)
Mesent. lymph node TLR1-9 HE, except TLR1,4,6
qRT-PCR Quantitative real-time reverse transcription-polymerase chain reaction, PIM pulmonary intravascular macrophages, LE level of
expression, IHC immunohistochemistry (includes detection by fluorescence), EMICC electron microscope immunocytochemistry, RT-PCR reverse
transcription-polymerase chain reaction, mesent. mesenteric, CEC colonic epithelial cells.
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TLR1LA and LB, and so is TLR2, replaced by TLR2A and
TLR2B as a result of gene duplication. There is also TLR15
(unique to birds) and TLR21 (shared with fishes). Chicken
TLR21 is an innate CpG DNA receptor distinct from
mammalian TLR9 (Brownlie et al. 2009; Keestra et al.
2010). In the zebra finch, an additional gene duplication
occurred in TLR7 (Brownlie et al. 2009). Thus, the
recognition spectrum of PAMP.is almost identical in birds
and mammals.
As far as downstream signaling is concerned, the
MyD88-mediated pathway appears to be expressed, but
the TRIF-TRAM-mediated pathway may be missing
(Keestra and van Putten 2008). This has been related to
markedly lower sensitivity to LPS of birds compared to
mammals.
Interestingly, linkage analyses suggested that certain
forms of chicken TLR4 are associated with resistance/
suseptibility to systemic infection of young chickens with
Salmonella enterica serovar Typhimurium (Leveque et al.
2003).
Teleostean fishes
Despite their high degree of variation, teleostean fishes all
have a similar TLR system and share functional properties
with those of mammals in principle, but some distinct
features are noted (Rebl et al. 2010). Bony fishes tend to
have more TLR members than mammals. In approximately
a dozen teleostean species, 17 TLR members were found
(TLR1, 2, 3, 4, 5, 6, 7, 8, 9, 13, 14, 18, 19, 20, 21, 22, 23)
(Rebl et al. 2010). They may be grouped in 6 major
families (TLR1/2, 3, 4, 5, 7, 11) (Roach et al. 2005). There
is also a soluble TLR5 variant (designated TLR5S). The
TLR7 family comprises TLR9 that has specificity for CpG
DNA rather than single-strand RNA, as have other
representatives of this group. In some fish species, there is
extensive gene duplication (e.g., TLR8.1 and TLR8.2), and
use of different splice variants (e.g., TLR9.1 and TLR9.2).
The two-digit TLR members are within the TLR11 family
except TLR-14 (TLR-1/2 family; Roach et al. 2005), and
they are referred to as “fish TLR”, as this order experienced
extensive gene duplication in some teleost species, whereas
in the mouse, it is represented by murine TLR11, 12 and 13
only, and in humans, there is only a pseudogene of TLR22.
TLR22 has been shown in the fugu (Takifugu rupripes) to
induce type-1-IFN, thereby being a functional analog of
TLR3. As stated above, a PAMP at the molecular level is
not known for this family in mammals. Quite clearly, there
are more gene duplications in teleosts than in mammals,
and the redundancy appears to be higher.
It has been pointed out by Rebl et al. (2010) that these
TLR, in order to function like mammalian TLR, have to
interact with down-stream signal transduction molecules.
There is functional evidence that piscine MyD88 is
interacting with TIR domains (van der Sar et al. 2006),
but the piscine IFN-activating pathway differs from the
mammalian one. The Tollip molecule has also been found
in teleosts either in one or several different variants (Rebl
et al. 2008)
Lamprey
The Japanese lamprey genome contains 16 TLR genes,
some of which are M-type (“mammalian-type”), and F-type
(“fish-type”), respectively. Remarkably, neither IRF3 nor
IRF7 was expressed, two essential signaling molecules in
the mouse, leading to type-I-IFN production, although the
upstream molecules of the signaling chain were highly
conserved between lamprey and mammals (Kasmatsu et al.
2010).
Functional variation of TLR in mammals
Being a well-conserved system, one may not expect great
differences in TLR functions since most domestic animals
are mammals and thus are relatively close to each other in
phylogeny. Nevertheless, there are some species-specific
differences in ligand recognition (Werling et al. 2009;
Fitzgerald et al. 2004). The lipid A analog C406 acts as an
agonist for murine but as an antagonist for human TLR4
(Tamai et al. 2003). LPS from Rhodobacter sphaeroides
was shown to activate horse and hamster TLR4 but not
human and murine TLR4 (Lohmann et al. 2007). TLR2/6
and TLR2/1 heterodimers recognize diacylated and triacy-
lated LP, respectively. Depending on the species, fatty acids
of a maximal length of 6, 12 or l4 C atoms are recognized
by the mouse, cattle or human, respectively (Farhat et al.
2010). The requirements for optimal recognition of the
murine, the bovine or the human TLR9 differs between
species (Zhang et al. 2001). One of the receptors for the
recognition of Salmonella enterica serovar Typhimurium is
TLR5 as it recognizes bacterium-derived flagellin. Chicken
and mouse TLR5 were consistently more sensitive to
flagellin from this organism than human TLR5, a species-
restricted particularity controlled by one single amino acid
of this type of flagellin (Keestra et al. 2008). Thus, although
the TLR system is conserved in principle in mammals,
some subtle species-specific variations are observed.
TLR expression by various tissues
The interface between a potential host and a microbe
coming from the surroundings are either immune cells or
epithelia. So, expression of TLR members must be highest
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and most varied in mononuclear phagocytes, neutrophils/
heterophils, dendritic cells and epithelial cells such as
enterocytes. However, dendritic cells are not uniform, and
expression levels of TLR are quite different between types
of dendritic cells (Werling et al. 2006). The same applies to
mononuclear cells. Several studies refer to expression of
TLR members by ocular tissue (Pearlman et al. 2010;
Redfern and McDermott 2010). Although it is generally
assumed that a high level of expression of a given TLR
member indicates an efficient response to a PAMP, the
study of expression is complicated by several factors: (1) it
is not always clear whether nonexisting reports on certain
TLR member expression means the virtual absence of a
given TLR member from this tissue or organ, or a lack of
relevant tools for analysis, or simply lacking information;
(2) it is difficult to delineate experimentally a threshold
between scarce and lacking expression, and using RT-PCR
or qRT-PCR it is difficult to estimate the level of expression
at the protein level; (3) the expression levels can be
modulated by various factors, e.g., cytokines or PAMP
themselves (see below); and (4) in whole organs with many
different tissues, it is not clear whether this means a given
TLR member is highly expressed in this organ at large, or
whether a high-expressing tissue (e.g., blood cells) causes
this result. Nevertheless, for quick information, an attempt
to summarize what is known on TLR expression levels in
domestic animals is presented in Table 1, which may be
consulted for getting an impression of the most important
organs. Most revealing are such data if antibodies are
available, allowing the study of protein expression by
individual cells rather than mRNA expression of the organ
at large. Therefore, the method by which a result was
obtained is also given in Table 1. Most work has been done
on TLR2 and TLR4, as these are regarded as major PRR for
gram-positive and -negative bacteria, respectively. As the
TLR system is conserved, in mammals, one may, as a first
estimate, extrapolate from one species to another. Looking
at Table 1, it is surprising that both partners of heterodimers
are not always coexpressed, i.e. that TLR2 may be
expressed, but neither TLR1 nor TLR6.
TLR4, the best-studied TLR member, appears to be
expressed in various species (pig, dog, cattle) bymacrophages
and epithelial cells of the normal lung, small intestine, liver,
spleen, kidney, cornea, but not in the normal skin and in
skeletal muscles (Wassef et al. 2004; Tirumurugaan et al.
2010). For details, the reader is referred to Turin and Riva
(2008).
The laboratory of Baljit Singh succeeded in assessing
expression of TLR2, 4 and 9 in the unstimulated horse lung
(Singh Suri et al. 2006; Schneberger et al. 2009). Moreover,
they had antibodies crossreacting with equine TLR4. That
TLR2 is expressed in pulmonary vascular macrophages
exclusively is based on circumstantial evidence. Also, for
TLR4. the level of expression was higher in PIM than in
other lung cells.
Quite recently, evidence for expression of TLR2, 4 and 9
was reported for a porcine cell line (IPEC-J2) (Burkey et al.
2009). Another study showed that porcine TLR2 is
expressed by intestinal M cells (Tohno et al. 2005b), and
that TLR9 is also expressed in swine Peyer’s patches
(Tohno et al. 2006). These authors had access to TLR2-
specific and TLR9-specific polyclonal antibodies (Tohno
et al. 2005b; Shimosato et al. 2005).
Modulation of TLR expression and activity
Under modulation, we understand up- or down-regulation
of TLR expression and function. There are several ways
how to modulate TLR expression: (1) specific modulation
by TLR agonists; (2) specific modulation of other immune-
related parameters as a result of TLR triggering; (3) non-
specific modulation of TLR expression by any compound,
or by the underlying disease; and (4) induction of
regulatory T cells (Treg) (Nyirendra et al. 2009). A word
of warning is also appropriate here. It may be that the level
of expression and the function are dissociated. Thus, we
observed in bovine mononuclear cells expression of both
TLR2 and TLR4, but the levels of expression were
uninfluenced by IFN-γ, quite in contrast to their response
to LPS (Jungi and Sauter, unpublished).
In the study reported on dogs with chronic enteropathies
(Burgener et al. 2008), there is a general upregulation of
TLR2 and TLR4. McMahon et al. (2010) also showed that,
in inflammatory bowel disease of the dog, there is an up-
regulation of TLR2 in the duodenum, and regarding up-
regulation of TLR4, there was a definitive trend but levels
of significance were not reached (McMahon et al. 2010). In
the latter study, more mildly ill dogs were enrolled than in
the former. In dogs with oligoarthritis and degenerative
cranial cruciate ligament rupture, the expression of several
genes involved in immune responses, among these TLR2
and 9, were found to be elevated on synovial cells (Muir
et al. 2007), although there was wide variation. What is
surprising in this study is that a comparison with healthy
dogs was made, which have a very small volume of
synovial fluid and a low number of synovial cells.
In the dog, both TLR2 and 4 appear to be expressed
weakly by normal colonic epithelial cells, and they are
dramatically up-regulated by prior treatment of the cells
with the respective MAMP (Swerdlow et al. 2006). In cattle
and horses, TLR2 and TLR4 were up-regulated after
exposure to LPS or TLR2 ligands (Ibeagha-Awemu et al.
2008; Singh Suri et al. 2006). A study suggested that
activation of TLR3, but not TLR4, leads to increased
resistance to infection with porcine reproductive and
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respiratory syndrome virus (PRRSV) (Akashi et al. 2000).
In some cases, specific stimulation by a TLR agonist has a
tolerizing effect. For example, stimulation of TLR5 by
Salnonella flagellin results in tolerization of these and in
blockade of NF-κB-mediated gene induction (Sun et al.
2007). Prolonged or repeated stimulation of TLR5 also
leads to their refractoriness. Similarly, prior exposure of
human epithelial cells to flagellin ofPseudomonas aeruginosa
tolerized these in that a subsequent TLR5 stimulation by P.
aeruginosa no longer had a deleterious effect, and the innate
and potentially harmful response was weakened (Kumar
et al. 2007). That TLR engagement may be counterproduc-
tive has been shown by Lang et al. (2005). It has been found
that expression in the pancreas of an antigen to which all
transgenic cytotoxic T cells are specific is not attacked
(Ohashi et al. 1993), but when infected with the virus
(Ohashi et al. 1993), when applying TNF (Ohashi et al.
1993) or when stimulating the TLR system (Lang et al.
2005), tolerance is broken, and autoimmune disease—in this
case diabetes—results. Using porcine reproductive and
respiratory syndrome virus (PRRSV), it was shown that
infection with this virus led to a reduction of LTA-induced
IL-1 production and LTA- or LPS-induced IL-6 production
by macrophages (Chaung et al. 2008; Liu et al. 2009).
Furthermore, infection of bovine alveolar macrophages with
M. bovis may silence other TLR-related signaling pathways,
and may induce some sort of cross-tolerance induction to
other PAMP, similar to that described for other species
(Piercy et al. 2007).
The expression of 9 TLR members was studied in
various feline tissues with a view to investigating modula-
tion by infection with feline immunodeficiency virus (FIV)
(Ignacio et al. 2005). A complex pattern of up- or down-
regulation induced by FIV for all members of the TLR
family was obtained.
Considering that there are roughly 10 domestic animal
species, about 10 TLR members, 20 or so tissues to be
analyzed, and many potentially modulatory treatments, one
grasps immediately that the information available on
modulation is sketchy, at best. But diseases are species-
specific. It makes sense that one has studied preferentially
modulation of TLR expression by disease and their therapy.
TLR and diseases
When the Bern laboratory started working on TLR of
domestic animals, there was the theoretical concept of TLR
as PRR (Werling and Jungi 2003). But there was no
recognized disease associated with a dysregulation of TLR
members or TLR signaling. This has dramatically changed.
We now know that modulating either TLR expression or
TLR-mediated function may alter both innate and adaptive
immune reaction. This knowledge can be utilized not only
in vaccination protocols to optimize immunostimulatory
effects of antigens but also in other situation, e.g., in the
control of allergies.
Allergic diseases are governed by a Th2 response, and
triggering of TLR favors a Th1 response, thereby inhibiting
allergic reactions and other Th2-mediated responses (see
review of Gangloff and Guenounou 2003). Although it may
not be possible to identify a defunct TLR member or
signalling compound, a tolerization of the TLR system
occurs, e.g., due to previous stimulation of the TLR system.
Alternatively, TLR stimulation may lead to the induction of
Treg and dampens an adaptive immune response. Examples
of this kind are numerous and are summarized by
Nyirendra et al. (2009).
TLR polymorphisms
Here, domestic animals might provide some interesting
clues as pathogens cause, in most cases, a species-specific
health problem, and it is the coevolution of host and
pathogen that shaped TLR sequences, particularly the
extracellular, leucine-rich repeats (LRR). The cases
reported are not as clearcut as in the case of the C3H/HeJ
mouse which contains a missense mutation, rendering the
response to LPS an all-or-none question (Poltorak et al.
1998). Nevertheless, cases of an inheritable trait favoring
certain diseases have been reported, and we can still learn
from non-synonymous single nucleotide polymorphism
(NSSNP), although the pathogen(s) shaping TLR LRR is/
are most often unknown. The proportion of NSSNP gives
us some information as to whether a sequence is genetically
stable, or whether evolution drives the amino acid sequence
away from the original one. Most often, NSSNP have been
listed without association of a given disease.
Ruminants
In genes of many ruminants, including TLR members and
TLR-adapter proteins, NSSNP have been identified. At
least 54 NSSNP in 11 bovine innate immune genes [TLR1–
10, peptidoglycan recognition receptor number 1 (PGLYRP1)]
have been identified for 37 cattle breeds, with an average
polymorphic density of one alteration per 219 base pairs
(Seabury et al. 2010). Interestingly, however, Bos taurus
taurus and Bos taurus indicus breeds appear to have
haplotype sharing at every locus. However, the actual
number of NSSNP might be considerably higher (Jann
et al. 2009), and may also indicate selective pressure in
ruminant TLR compared to other mammalian TLR in the
region necessary for ligand binding/heterodimerization
(Werling et al. 2009). Whereas a direct link of such TLR-
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NSSNP in ruminants to a specific disease might be hard to
obtain, a recent comarative genomic approach identified
eight genes as potentially causative genes for variations of
health-related traits (Jann et al. 2009). These include
susceptibility to clinical mastitis in dairy cattle, general
disease resistance in sheep, cattle, human and mice, and
tolerance to protozoan infection in cattle and mice. Four
TLR-related genes (TLR1, 6, MyD88, IRF3) appear to be the
most likely candidate genes underlying quantitative trait loci
(QTL) which control the resistance to the same or similar
pathogens in several species (Jann et al. 2008).
Fine examples of an association between infectious
disease and mutations have been reported by Bhide, Mucha
and collaborators. Novel NSSNP of cattle TLR were
reported, some of which were found to be associated with
facilitated infection with Mycobacterium avium subsp.
paratuberculosis, the causative agent of Johne’s disease
(Mucha et al. 2009). In sheep, there was also an association
between novel NSSNP in TLR1 and TLR2 and the severity of
infection withMycobacterium avium subsp. paratuberculosis
(Bhide et al. 2009).
Pig
In the pig, 21, 11, 7 and 13 NSSNP were found in TLR 2,
4, 5 and 6, respectively, many of which are in the
extracellular LRR (Shinkai et al. 2006b). The biased
distribution suggests that these NSSNP are the result of
coevolution of host and certain unknown pathogens,
Despite intensive breeding, heterozygosity with regard to
TLR is apparently an advantage. In another porcine study,
TLR1, 6 and 10 genes have been completely (re)-sequenced
(Shinkai et al. 2006a). An analysis of the cytoplasmatic
portion (Fig. 1) suggested that the signal transduction
pathway of TLR10 is different from that of the closely
related TLR1 and 6 (Shinkai et al. 2006a). This is
surprising, as in the mouse and in human, TLR1, 2, 6,
and 10 all express a TIR domain interacting with MyD88
and are thought to mediate NF-κB activation. In the latter
study, six polymorphic microsatellite markers within the
genetic regions of TLR1, 6 and 10 were developed as they
might be useful in association studies of TLR variants and
resistance to disease. According to a more recent study, in
the genes coding for porcine TLR1, 2 and 6, a total of 20,
26 and 27 NSSNP were found, respectively (Bergman et al.
2010).
Horse
In the horse, a total of 13 SNP were found in TLR3, 7 and
8 (Astakhova et al. 2009). Allelic frequencies were
determined in 154 horses belonging to 5 different breeds.
A comparison with TLR3, 7 and 8 from other mammals
revealed several conserved regions within the variable
LRR. This is in line with an earlier study specifically
looking at TLR4 and showing a restricted degree of
polymorphism in horse TLR4 (Vychodilova-Krenkova
et al. 2005).
Concluding remarks
A lot of information has been generated from the study of
either the murine or the human TLR system, since these
species appear to be the most interesting and the most
accessible. The tacit assumption that the TLR system in all
higher vertebrates is alike roots in two facts. Firstly, not
many tools exist for the study of the TLR system of
domestic animal species. Although working in principle in
several species, the use of the knockout technology, which
was essential for progress, favors to study the TLR system
in mice. Humans are more interesting than domestic animal
species for researchers and their sponsors. Secondly, given
the fact that the TLR system is locked by both MAMP
recognition and interaction with signaling molecules, which
have been conserved, this system could not deviate a lot in
evolutionary terms, which provides a rationale for compar-
ing chickens, fishes and mammals in order to learn more
about evolutionary constraints. Nevertheless, since recog-
nition by the TLR system is associated with adaptive
immunity, by learning more about the TLR system in
domestic animals, one might learn more about adjuvants in
vaccines, as the TLR system provides optimal immunosti-
mulation. In other words, if it is understood how to
stimulate maximally the TLR system may be the key to
immunize optimally. Therefore, to study domestic animal
species with regard to the TLR system might not only tell
us about the constraints imposed by pathogens of a given
species; it also might provide an optimal vaccine regime in
the species studied.
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